Behr T - Search Results

1

Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.

Juweid M, Sharkey RM, Markowitz A, Behr T, Swayne LC, Dunn R, Hansen HJ, Shevitz J, Leung SO, Rubin AD, et al. Juweid M, et al. Among authors: behr t. Cancer Res. 1995 Dec 1;55(23 Suppl):5899s-5907s. Cancer Res. 1995. PMID: 7493367 Clinical Trial.

2

Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake.

Juweid M, Sharkey RM, Siegel JA, Behr T, Goldenberg DM. Juweid M, et al. Among authors: behr t. Cancer Res. 1995 Dec 1;55(23 Suppl):5827s-5831s. Cancer Res. 1995. PMID: 7493354

3

Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies.

Sharkey RM, Juweid M, Shevitz J, Behr T, Dunn R, Swayne LC, Wong GY, Blumenthal RD, Griffiths GL, Siegel JA, et al. Sharkey RM, et al. Among authors: behr t. Cancer Res. 1995 Dec 1;55(23 Suppl):5935s-5945s. Cancer Res. 1995. PMID: 7493374 Clinical Trial.

4

Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen.

Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Hanley D, Herskovic T, Markowitz A, Siegel J, Goldenberg DM. Juweid M, et al. Among authors: behr t. Cancer Res. 1995 Dec 1;55(23 Suppl):5946s-5951s. Cancer Res. 1995. PMID: 7493375 Clinical Trial.

5

Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.

Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Herskovic T, Hanley D, Markowitz A, Dunn R, Siegel J, Kamal T, Goldenberg DM. Juweid M, et al. Among authors: behr t. J Clin Oncol. 1996 Apr;14(4):1209-17. doi: 10.1200/JCO.1996.14.4.1209. J Clin Oncol. 1996. PMID: 8648376

6

Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies.

Juweid M, Sharkey RM, Behr T, Swayne LC, Herskovic T, Pereira M, Rubin AD, Hanley D, Dunn R, Siegel J, Goldenberg DM. Juweid M, et al. Among authors: behr t. J Nucl Med. 1996 Jun;37(6):905-11. J Nucl Med. 1996. PMID: 8683309 Free article.

7

Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2.

Juweid ME, Sharkey RM, Behr T, Swayne LC, Dunn R, Siegel J, Goldenberg DM. Juweid ME, et al. Among authors: behr t. J Nucl Med. 1996 Sep;37(9):1504-10. J Nucl Med. 1996. PMID: 8790202 Free article.

8

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.

Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, Bair HJ, Wolf FG, Becker WS, Goldenberg DM. Behr TM, et al. Cancer Res. 1995 Sep 1;55(17):3825-34. Cancer Res. 1995. PMID: 7641200

9

Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.

Behr TM, Sharkey RM, Juweid MI, Dunn RM, Ying Z, Zhang CH, Siegel JA, Gold DV, Goldenberg DM. Behr TM, et al. Cancer Res. 1996 Apr 15;56(8):1805-16. Cancer Res. 1996. PMID: 8620497

10

Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2.

Juweid M, Sharkey RM, Behr TM, Swayne LC, Dunn R, Ying Z, Siegel JA, Hansen HJ, Goldenberg DM. Juweid M, et al. Among authors: behr tm. Cancer. 1996 Jul 1;78(1):157-68. doi: 10.1002/(SICI)1097-0142(19960701)78:1<157::AID-CNCR22>3.0.CO;2-Y. Cancer. 1996. PMID: 8646712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters